Guest guest Posted December 28, 2004 Report Share Posted December 28, 2004 As you all know, last year's decision by the FDA to finalize the rule regarding the anthrax vaccine had been withdrawn. It is back to an unknown status for the next 90 days while the FDA takes public comment on the vaccine. Below is the summary, instructions and links for submitting your comments. Now is your opportunity to have your voice be heard, please share your experience and/or your opinions. Your comments will be made public; though not private, they are protected. Add your voice to this critical effort - and forward to everyone you know that may also want to contribute. To read, go to: http://www.fda.gov/cber/rules/bvactox.pdf Instructions: All submissions received must include the agency name and Docket No. for this proposal. You may submit comments, identified by Docket No. 1980N-0208, by any of the following methods: " Federal eRulemaking Portal: http://www.regulations.gov. " Agency Web site: http://www.fda.gov/dockets/ecomments. " E-mail: fdadockets@.... Include Docket No. in the subject line of your e-mail message. " FAX: 301-827-6870. " Mail/Hand delivery/Courier [For paper, disk, or CD-ROM submissions]: Division of Dockets Management, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments received will be posted without change to http://www.fda.gov/ohrms/dockets/default.htm, including any personal information provided. For detailed instructions on submitting comments and additional information on the process, see the " Comments " heading of the SUPPLEMENTARY INFORMATION section of this document. Docket: For access to the docket to read background documents or comments received, go to http://www.fda.gov/ohrms/dockets/default.htm and insert the docket number found in brackets in the heading of this document, into the " Search " box and follow the prompts and/or go to the Division of Dockets Management, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Randi Airola www.milvacs.org www.mvacpac.org 517-819-5926 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.